Valeric acid induces cell cycle arrest at G1 phase in CHO cell cultures and improves recombinant antibody productivity
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
To find a more effective chemical reagent for improved monoclonal antibody (mAb) production, eight chemical reagents (curcumin, quercein, DL‐sulforaphane, thymidine, valeric acid, phenyl butyrate, valproic acid, and lithium chloride) known to induce cell cycle arrest were examined individually as chemical additives to recombinant CHO (rCHO) cell cultures producing mAb. Among these chemical additives, valeric acid showed the best production performance. Valeric acid decreased specific growth rate (μ), but increased culture longevity and specific mAb productivity (qmAb) in a dose‐dependent manner. The beneficial effect of valeric acid on culture longevity and qmAb outweighed its detrimental effect on μ, resulting in 2.9‐fold increase in the maximum mAb concentration when 1.5 mM valeric acid was added to the cultures. Furthermore, valeric acid did not negatively affect the mAb quality attributes with regard to aggregation, charge variation, and galactosylation. Unexpectedly, galactosylation of the mAb increased by the 1.5 mM valeric acid addition. Taken together, the results obtained here demonstrate that valeric acid is an effective chemical reagent to increase mAb production in rCHO cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Valproic and valeric acid molecular mechanisms affecting glycosylation remain unresolved, though they are expected to be similar to those proposed for NaBu.58,59”
From Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis (2026) · cites this paper as [59]
Citations
Cites
Sodium butyrate inhibits histone deacetylation in cultured cells
Candido, E. (1978) · Cell · doi:10.1016/0092-8674(78)90305-7 · Cited by 1,036
Terminal sugars of Fc glycans influence antibody effector functions of IgGs
Raju, T. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.007 · Cited by 521
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
Butler, M. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1980-8 · Cited by 469
Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro
Hodoniczky, J., Zheng, Y. Z., & James, D. C. (2005) · Biotechnology Progress · doi:10.1021/bp050228w · Cited by 393
Yoon, S. K., Song, J. Y., & Lee, G. M. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10566 · Cited by 241
Self-citationFimognari, C. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.581 · Cited by 237
Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980405)58:1<73::aid-bit8>3.0.co;2-r · Cited by 220
Heerdt, B. G., Houston, M. A., & Augenlicht, L. H. (1997) · PubMed · Cited by 206
Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins
Weikert, S., Papac, D., Briggs, J., Cowfer, D., Tom, S., Gawlitzek, M., Lofgren, J., Mehta, S., Chisholm, V., Modi, N., et al. (1999) · Nature Biotechnology · doi:10.1038/15104 · Cited by 202
Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
Gramer, M. J., Eckblad, J. J., Donahue, R., Brown, J., Shultz, C., Vickerman, K., Priem, P., van den Bremer, E. T. J., Gerritsen, J., & van Berkel, P. H. C. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23075 · Cited by 193
Research works printed but not linked: 1
- 10.1002/1097-0290(2000)71:3<184::aid-bit1008>3.0.co;2-w · doi:10.1002/1097-0290(2000)71:3<184::aid-bit1008>3.0.co;2-w
Cited by
Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review
Bielser, J.-M., Wolf, M., Souquet, J., Broly, H., & Morbidelli, M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.04.011 · Cited by 263
“Valeric acid, which is much cheaper than chemicals used in this context, was reported to increase mAb productivity in a fed-batch process without impacting quality attributes (Park et al., 2015).”
BackgroundPark, J. H., Jin, J. H., Lim, M. S., An, H. J., Kim, J. W., & Lee, G. M. (2017) · Scientific Reports · doi:10.1038/srep44246 · Cited by 96
Self-citationHa, T. K., Kim, D., Kim, C. L., Grav, L. M., & Lee, G. M. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107831 · Cited by 74
Self-citationSerum-Free Medium for Recombinant Protein Expression in Chinese Hamster Ovary Cells
Li, W., Fan, Z., Lin, Y., & Wang, T. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.646363 · Cited by 74
Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications
MacDonald, M. A., Nöbel, M., Roche Recinos, D., Martínez, V. S., Schulz, B. L., Howard, C. B., Baker, K., Shave, E., Lee, Y. Y., Marcellin, E., et al. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1998821 · Cited by 55
Improved Performance in Mammalian Cell Perfusion Cultures by Growth Inhibition
Wolf, M., Closet, A., Bzowska, M., Bielser, J., Souquet, J., Broly, H., & Morbidelli, M. (2018) · Biotechnology Journal · doi:10.1002/biot.201700722 · Cited by 53
Huang, Z., Xu, J., Yongky, A., Morris, C. S., Polanco, A., Reily, M. D., Borys, M., Li, Z. J., & Yoon, S. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107638 · Cited by 53
Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells
Geng, S., Zhao, X., Zhang, X., Zhang, J., Mi, C., & Wang, T. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13008-6 · Cited by 51
“Studies have confirmed that valeric acid (VA) affects glycosylation and is conducive to terminal galactosylation of mAbs (Park et al. 2016).”
Park, J. H., Lim, J., Woo, J. R., Kim, J., & Lee, G. M. (2016) · Biotechnology Progress · doi:10.1002/btpr.2287 · Cited by 45
“025 cells were established using glutamine synthetase (GS)-mediated gene amplification.(18) The GS gene converts glutamate to glutamine, and therefore, SM-0.”
BackgroundMethodInfluentialSelf-citationComparative proteomic analysis of three Chinese hamster ovary (CHO) host cells
Xu, N., Ma, C., Ou, J., Sun, W., Zhou, L., Hu, H., & Liu, M. (2017) · Biochemical Engineering Journal · doi:10.1016/j.bej.2017.05.007 · Cited by 43
“14 phase arrest during cell cycle to improve cellular metabolism [38, 39].”
BackgroundZinc supplementation decreases galactosylation of recombinant IgG in CHO cells
Prabhu, A., Gadre, R. V., & Gadgil, M. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9064-8 · Cited by 34
Torres, M., & Dickson, A. J. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.28000 · Cited by 34
“Similar improvements in cell‐specific productivity have resulted from the use of chemical chaperones (e.g., valeric acid) (Park et al., 2016) or proprietary cell cycle inhibitors (Du et al., 2015).”
BackgroundExacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate
Prow, N. A., Hirata, T. D. C., Tang, B., Larcher, T., Mukhopadhyay, P., Alves, T. L., Le, T. T., Gardner, J., Poo, Y. S., Nakayama, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02736 · Cited by 33
Ha, T. K., Hansen, A. H., Kildegaard, H. F., & Lee, G. M. (2019) · Biotechnology Journal · doi:10.1002/biot.201900130 · Cited by 30
Self-citationMöller, J., Korte, K., Pörtner, R., Zeng, A., & Jandt, U. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26828 · Cited by 26
Kim, S. H., Baek, M., Park, S.-J., Shin, S., Lee, J. S., & Lee, G. M. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.11.001 · Cited by 25
Self-citationClonal variations in CHO IGF signaling investigated by SILAC-based phosphoproteomics and LFQ-MS
Schelletter, L., Albaum, S. P., Walter, S., Noll, T., & Hoffrogge, R. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10020-z · Cited by 21
Coronel, J., Heinrich, C. A., Klausing, S., Noll, T., Figueredo‐Cardero, A., & Castilho, L. R. (2019) · Biotechnology Progress · doi:10.1002/btpr.2915 · Cited by 22
“Park et al.(41) reported a percentage of 78.”
BackgroundResultInfluentialXu, P., Xu, S., He, C., & Khetan, A. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107577 · Cited by 20
Zhu, Z., Chen, X., Li, W., Zhuang, Y., Zhao, Y., & Wang, G. (2023) · Biotechnology Progress · doi:10.1002/btpr.3352 · Cited by 21
Toronjo‐Urquiza, L., Acosta‐Martin, A. E., James, D. C., Nagy, T., & Falconer, R. J. (2020) · Biotechnology Progress · doi:10.1002/btpr.2980 · Cited by 19
Wallocha, T., & Popp, O. (2021) · Processes · doi:10.3390/pr9112073 · Cited by 18
Kang, D. E., An, Y. B., Kim, Y., Ahn, S., Kim, Y. J., Lim, J. S., Ryu, S. H., Choi, H., Yoo, J., You, W., et al. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12459-7 · Cited by 17
Self-citationKim, S. H., Shin, S., Baek, M., Xiong, K., Karottki, K. J. L. C., Hefzi, H., Grav, L. M., Pedersen, L. E., Kildegaard, H. F., Lewis, N. E., et al. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2023.09.006 · Cited by 18
Self-citationRapid at‐line early cell death quantification using capacitance spectroscopy
Wu, S., Ketcham, S. A., Corredor, C. C., Both, D. A., Drennen, J. K., & Anderson, C. A. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.28011 · Cited by 16
Zinc supplementation increases protein titer of recombinant CHO cells
Roca, B. C., Miguez, A. A., Keenan, J., Suda, S., Barron, N., O’Gorman, D. J., Doolan, P., & CLYNES, M. M. (2019) · Cytotechnology · doi:10.1007/s10616-019-00334-1 · Cited by 17
“More recently, Kim and Park (2016) reported the titer-associated benefits of high zinc supplementation of a DG44 culture growing in an in-house and commercial media, with up to 6.5-fold increase in mAb titer observed (Kim and Park 2016).”
BackgroundResultInfluentialEffects and mechanisms of animal-free hydrolysates on recombination protein yields in CHO cells
Du, Q.-J., Zhang, X., Wang, T., & Wang, X. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12229-x · Cited by 15
Perfusion Cell Culture Processes for Biopharmaceuticals: Process Development, Design, and Scale-up
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209 · Cited by 18
Kim, S. H., Park, J.-H., Shin, S., Shin, S., Chun, D., Kim, Y., Yoo, J., You, W., Lee, J. S., & Lee, G. M. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00646 · Cited by 15
Self-citationTian, J., He, Q., Oliveira, C. L., Qian, Y., Egan, S., Xu, J., Qian, N., Langsdorf, E. F., Warrack, B. M., Araníbar, N., et al. (2020) · Engineering in Life Sciences · doi:10.1002/elsc.201900124 · Cited by 14
Forskolin Increases cAMP Levels and Enhances Recombinant Antibody Production in CHO Cell Cultures
Yoon, C., Kim, D., Lim, J. H., & Lee, G. M. (2020) · Biotechnology Journal · doi:10.1002/biot.202000264 · Cited by 13
Self-citationDirected evolution of biomass intensive CHO cells by adaptation to sub-physiological temperature
Syddall, K. L., Fernandez‐Martell, A., Cartwright, J. F., Alexandru-Crivac, C. N., Hodgson, A., Racher, A. J., Young, R. J., & James, D. C. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2023.11.005 · Cited by 14
Ji, X., Lee, Y. J., Eyster, T., Parrillo, A. J., Galosy, S. S., Ao, Z., Patel, P., & Zhu, Y. (2021) · Biotechnology Progress · doi:10.1002/btpr.3211 · Cited by 16
Gadolinium induced effects on mammalian cell motility, adherence and chromatin structure
Nagy, G., Baksa, V., Kiss, A., Turáni, M., & Bánfalvi, G. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1311-9 · Cited by 11
Segar, K. P., Chandrawanshi, V., & Mehra, S. (2017) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2017.05.005 · Cited by 11
Kim, D., Yoon, C., & Lee, G. M. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.28013 · Cited by 12
“Several carboxylic acid‐based iHDACs, such as NaBu (Damiani et al., 2013), valproic acid (W. C. Yang et al., 2014), and valeric acid (Park et al., 2016), have been used as chemical additives in rCHO cell cultures.”
MethodSelf-citationBauer, N., Oswald, B., Eiche, M., Schiller, L., Langguth, E., Schantz, C., Osterlehner, A., Shen, A. Y., Misaghi, S., Stingele, J., et al. (2022) · Synthetic Biology · doi:10.1093/synbio/ysac026 · Cited by 11
Kim, D., Kim, S. H., Yoon, C., & Lee, G. M. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28611 · Cited by 10
“Addition of small molecules to the culture medium, which can be easily implemented in industrial processes, is a simple and efficient means of enhancing therapeutic protein production in recombinant CHO (rCHO) cell culture (Park et al., 2016).”
BackgroundMethodSelf-citationCapacitance spectroscopy enables real‐time monitoring of early cell death in mammalian cell culture
Wu, S., Ketcham, S. A., Corredor, C. C., Both, D. A., Drennen, J. K., & Anderson, C. A. (2022) · Biotechnology Journal · doi:10.1002/biot.202200231 · Cited by 10
Rahimi-Zarchi, M., Shojaosadati, S. A., Amiri, M. M., Jeddi‐Tehrani, M., & Shokri, F. (2018) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-018-1927-y · Cited by 10
“Cell cycle inhibition approaches have been widely used to increase Qp in cell cultures [8, 9], including nutrient limitation, culturing the cells at low temperatures [10, 11], addition of small molecule enhancers (SMEs) like sodium butyrate (NaBu) [9, 12] and cell engineering by overexpression of endogenous cyclin-dep…”
MethodBojar, D., Fuhrer, T., & Fussenegger, M. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.11.007 · Cited by 12
Meyer, H., Turincio, R., Ng, S., Li, J., Wilson, B., Chan, P., Zak, M., Reilly, D. E., Beresini, M. H., & Wong, A. W. (2017) · Biotechnology Progress · doi:10.1002/btpr.2517 · Cited by 9
“that an increase of cells in G1 phase correlates with higher recombinant protein levels in stable CHO cell lines.(12,17,20) For transient gene expression, Tait et al.”
BackgroundJarusintanakorn, S., Mastrobattista, E., & Yamabhai, M. (2024) · New Biotechnology · doi:10.1016/j.nbt.2024.06.006 · Cited by 8
Endogenous p21-Dependent Transgene Control for CHO Cell Engineering
Lee, Y., Kwak, J. M., & Lee, J. S. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00526 · Cited by 8
Chakrabarti, L., Savery, J., Mpindi, J. P., Klover, J., Li, L., & Zhu, J. (2024) · Biotechnology Progress · doi:10.1002/btpr.3441 · Cited by 7
“22 Here for the ETE mAb,”
Hua, J., Wei, Y., Zhang, Y., Xu, H., Ge, J., Liu, M., Wang, Y., Shi, Y., Hou, L., & Jiang, H. (2022) · Protein Expression and Purification · doi:10.1016/j.pep.2022.106154 · Cited by 7
Bravo-Venegas, J., Rodriguez-Siza, J., Vergara, M., Torres, M., Dickson, A., Toledo, J. R., Molina, M. C., Hermoso, M. A., Berríos, J., & Altamirano, C. (2026) · mAbs · doi:10.1080/19420862.2026.2643039 · Cited by 6
“58,59 For example, CDK4/6 inhibitors induced G0/G1 arrest in CHO cells and increased galactose and fucose occupancy ( ∆GIx 2–5”
Kiszel, P., Fiesel, S., Voit, S., Waechtler, B., Meier, T., Oelschlaegel, T., Schräml, M., & Engel, A. M. (2019) · Biotechnology Progress · doi:10.1002/btpr.2786 · Cited by 7
“relaxation of chromatin structure and promoting access to transcriptionally machinery.(21,22) However, these transcriptional effects are selective and can cause induction or repression of gene expressions.”
BackgroundKido, M., Idogaki, H., Nishikawa, K., & Ōmasa, T. (2020) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2020.07.005 · Cited by 7
Aki, Y., Katsumata, Y., Kakihara, H., Nonaka, K., & Fujiwara, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250416 · Cited by 5
“For example, valeric acid, valproic acid, CDK4/6 inhibitor, galactose, manganese, and uridine encourage galactosylation [18, 19, 22, 41, 42], while zinc and ammonia suppress galactosylation [43, 44].”
BackgroundBastos, M. S., Saalfeld, R. M., Costa, B. P., Garcia, M. C. R., Antunes, K. H., Rodrigues, K. F., Melo, D. A. D. S., Santarém, E. R., & de Oliveira, J. R. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116056 · Cited by 7
Sodium valproate promotes low metabolism and high protein expression in CHO-engineered cell lines
Li, H., Mo, R., Yue, J., Cheng, R., Li, D., Idres, Y. M., Yang, Y., Wen, Y., Li, X., & Feng, R. (2024) · Biochemical Engineering Journal · doi:10.1016/j.bej.2024.109362 · Cited by 4
Luo, Q., Zhou, J., Tang, W., Jiang, P., Wan, X., Ahmed, W., Mohsin, A., Zhuang, Y., & Guo, M. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106293 · Cited by 4
Kido, M., Idogaki, H., Nishikawa, K., Motoishi, K., & Ōmasa, T. (2020) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2020.03.001 · Cited by 3
Jarusintanakorn, S., Rangnoi, K., Yamabhai, M., & Mastrobattista, E. (2023) · Biotechnology Progress · doi:10.1002/btpr.3403 · Cited by 3
“This strategy can be achieved by adding chemical compounds such as valeric acid, 2 or catechin, 3 which can arrest cells in a specific phase of the cell cycle.”
BackgroundRecent advances in the production of recombinant factor IX: bioprocessing and cell engineering
Beauglehole, A., Recinos, D. R., Pegg, C. L., Lee, Y. Y., Turnbull, V. J., Herrmann, S., Marcellin, E., Howard, C. B., & Schulz, B. L. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2022.2036691 · Cited by 2
“Increases terminal galactosylation and decreases the ratio of G0F2, at the same time increasing the ratio of G0F and G1F and G0F2F [154].”
BackgroundInfluentialMammalian Fed‐batch Cell Culture for Biopharmaceuticals
Yang, W. C. (2019) · Wiley eBooks · doi:10.1002/9783527811410.ch13 · Cited by 2
Genome Variation, the Epigenome and Cellular Phenotypes
Baumann, M., Klanert, G., Vcelar, S., Weinguny, M., Marx, N., & Borth, N. (2019) · Wiley eBooks · doi:10.1002/9783527811410.ch5 · Cited by 3
Shi, B., Huang, J., Lin, Y., Han, W., Qiu, S., Zhang, D., Tang, J., & Hou, P. (2022) · Waste and Biomass Valorization · doi:10.1007/s12649-022-01900-z · Cited by 2
wang, X., Lin, Y., & Wang, T. (2025) · Research Square · doi:10.21203/rs.3.rs-6788918/v1 · Cited by 2
Föller, S., Regett, N., Lataster, L., Radziwill, G., & Takors, R. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13363-4 · Cited by 1
“This correlation aligns with independent studies showing that CHO cells in G1 phase exhibit enhanced productivity (Dutton et al. 2006; Park et al. 2016; Boer et al. 2004).”
Reyes, S., Voyer, R., Durocher, Y., Henry, O., & Pham, P. L. (2025) · Biotechnology Progress · doi:10.1002/btpr.70046 · Cited by 2
“…will be allowed to grow to a certain high density; then a process trigger such as lower temperature (31 (cid:1) C to 34 (cid:1) C from 37 (cid:1) C) or chemical addition (sodium butyrate, valeric acid) 67,68 will be introduced to keep cells in a biomass steady state while boosting the production.”
Prolonged autophagy induction correlates with host cell protein reduction in CHO cell culture
Sahoo, A., Tsukidate, T., Pendyala, G., Yang, R., Li, X., & Madabhushi, S. R. (2026) · Biotechnology Progress · doi:10.1002/btpr.88528 · Cited by 2
“45 Although glycan-processing enzymes such as galacto-syltransferases (B3galt, B4galt) and the UDP-galactose transporter (Slc35a2) were quantified in our dataset, they were not significantly differentially expressed under the conditions tested.”
Naddafi, F., Mahboudi, F., Tabarzad, M., Farahani, Z. A., Shirazi, F. H., & Davami, F. (2019) · PubMed Central · doi:10.22088/ijmcm.bums.8.1.55 · Cited by 1
Perfusion Mammalian Cell Culture for Recombinant Protein Manufacturing
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.001 · Cited by 2
Scale-Down Models and Sensors for Process Development
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.003 · Cited by 2
Cell line-specific impact of dexamethasone on the bioprocessing of Chinese hamster ovary cells
An, Y. B., Kang, D. E., Yoo, J., You, W., Baik, J. Y., & Hong, J. K. (2024) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-024-00100-x · Cited by 1
“Recombinant CHO-K1 [36], -”
Lim, J.-A., Lim, J.-H., Lee, J.-H., Cheon, S., Lee, G., Kim, Z., & Kim, D. (2024) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-024-00105-6 · Cited by 1
“A study demonstrating that 4-PBA enhances the titer of mAb while decreasing cell viability suggests that it may play a similar role in our culture system [22].”
Self-citationRoca, B. C., Meiller, J., Doolan, P., & CLYNES, M. M. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4104-0_1 · Cited by 2
Design and Optimisation of Mammalian Cell Perfusion Cultures
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.004 · Cited by 1
Investigating media supplements to enhance Chinese Hamster ovary cell culture
Roca, B. C. (2020) · Dublin City University Open Access Institutional Repository (Dublin City University)
Integrated multi-scale mathematical models for biologics process development
Grilo, M. D. J. L. (2019) · Spiral (Imperial College London) · doi:10.25560/81634
Perfusion Bioreactors:The Set-Up and Process Characterisation
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.002
沖縄における経済と企業経営に関する一考察(報告2,三大学共同シンポジュウム「地域づくりを考える」)
村上, 了. (2006)
Clinical- and Commercial-Scale Reactors
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.005
Mechanistic and Statistical Modelling of Bioprocesses
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.006
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209.007
Bastos, M. S., Rodrigues, K. F., Garcia, M. C. R., Luft, C., Tonial, G. V., Pavanato, G. M., Astarita, L. V., Gatti, B. B., Maito, F. L. D. M., Santarém, E. R., et al. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108436
Reyes Davila, J. S. (2024) · PolyPublie (École Polytechnique de Montréal)
Reifenberg, P., Benjamin, D., Mignon, M. L., & Zimmer, A. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1708088
Pengetahuan Dasar Laboratorium Medik
Supardan, A. D. (., Aryani, D. (., Amin, Y. (., Yuliawuri, H. (., Malik, R. (., Rahayuningsih, C. K. (., Idayanti, T. (., Perkasa, T. A. (., Agustin, R. D. (., Arisanty, D. (., et al. (2025) · Neliti
Pei, X., Liu, X., Wang, R., Ma, T., Zhang, B., & Xu, C. (2026) · AMB Express · doi:10.1186/s13568-026-02050-4
“Similar to valproic acid, the HDAC1 inhibitor valeric acid, when administered in a 2 L bioreactor, enhanced the monoclonal antibody production in rCHO cells by inducing G1 phase arrest (Park et al. 2016).”
Zhang, X., Liu, R., 杜秋杰, Han, X., Jia, B., Jia, Y., Li, W., Feng, H., Wang, T., & Wang, X. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153018
Föller, S., Teleki, A., & Takors, R. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70288
“Such a shift, characterized by reduced proliferation and increased protein production, has been described in high‐producer CHO cells and is generally considered favorable for bioprocess performance (de Boer et al. 2004; Fussenegger et al. 1997; Park et al. 2016; Verhagen et al. 2020).”
Metadata
- Authors
- Park, J. H., Noh, S. M., Woo, J. R., Kim, J. W., & Lee, G. M.
- Affiliations
- Korea Advanced Institute of Science and Technology (KR)
- New Drug Development Center Cheongju Republic of Korea
- Corresponding author
- Lee, Gyun Min
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2015-12-29
- Volume
- 11
- Issue
- 4
- Pages
- 487-496
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2192858588
- Cited by
- 81
- References
- 48
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 10 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 4 · 2016: 2
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korean Ministry of Education, Science and Technology (2011‐0031962)
- National Research Foundation (2014069603)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- valeric acid, monoclonal antibody production, recombinant CHO cells, cell cycle arrest, G1 cell cycle arrest, culture longevity, specific productivity, chemical additives, galactosylation, antibody aggregation, growth rate
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Survival, Cricetulus, Culture Media, Dose-Response Relationship, Drug, Galactose, Glycosylation, Cricetinae, Pentanoic Acids, Recombinant Proteins, CHO Cells, Cell Culture Techniques, Cell Proliferation, G1 Phase Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.